Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukapheresis”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Not applicableUnknownNCT03215004
What this trial is testing

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

Who this might be right for
HIV Infections
American Gene Technologies International Inc. 24
Not applicableStudy completedNCT03517917
What this trial is testing

Prospective Tissue Collection Research Protocol

Who this might be right for
Solid Tumor
AstraZeneca 221
Early research (Phase 1)Study completedNCT00968760
What this trial is testing

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Who this might be right for
LymphomaB-cell Lymphoma
M.D. Anderson Cancer Center 34
Early research (Phase 1)Study completedNCT01097590
What this trial is testing

Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
IBD Column Therapies International AB 23
Post-approval studies (Phase 4)Ended earlyNCT00947674
What this trial is testing

Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Asahi Kasei Medical Co., Ltd. 52
Not applicableStudy completedNCT00001756
What this trial is testing

Study of Mast Cell Precursors

Who this might be right for
MastocytosisHealthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 202
Early research (Phase 1)Ended earlyNCT04526509
What this trial is testing

Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors

Who this might be right for
Neoplasms
Adaptimmune 12
Large-scale testing (Phase 3)Study completedNCT00005782
What this trial is testing

Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait

Who this might be right for
Sickle Cell Trait
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Testing effectiveness (Phase 2)Study completedNCT02992743
What this trial is testing

Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma

Who this might be right for
Neoplasms
GlaxoSmithKline 23
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Not applicableStudy completedNCT00059423
What this trial is testing

Natural History Study for BEN

Who this might be right for
NeutropeniaAgranulocytosisHematologic Diseases+2 more
National Heart, Lung, and Blood Institute (NHLBI) 178
Not applicableUnknownNCT01576237
What this trial is testing

Multinational Haemapheresis Vigilance Study

Who this might be right for
Blood Donation With Hemapheresis
DGTI - Haemapheresis Vigilance Working Party 50,000
Not applicableStudy completedNCT02842112
What this trial is testing

Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hospices Civils de Lyon 123
Not applicableAvailableNCT03601442
What this trial is testing

CTL019 Out of Specification MAP for ALL or DLBCL Patients

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Diffuse Large B-cell Lymphoma (DLBCL)
Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT05003895
What this trial is testing

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma
National Cancer Institute (NCI) 38
Not applicableEnded earlyNCT00316069
What this trial is testing

Stem Cell Collection

Who this might be right for
Stem Cells
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 429
Not applicableEnded earlyNCT00001349
What this trial is testing

Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies

Who this might be right for
LeukopheresisPlasmapheresis
National Institute of Allergy and Infectious Diseases (NIAID) 205
Not applicableEnrolling By InvitationNCT03226704
What this trial is testing

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

Who this might be right for
LeukemiaLymphomaAcute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 120
Early research (Phase 1)Ended earlyNCT05943990
What this trial is testing

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
Adaptimmune 5
Testing effectiveness (Phase 2)Study completedNCT00040482
What this trial is testing

High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Baylor College of Medicine 10
Load More Results